J. Antenor

发表

Pathological characteristics of prostate cancer detected through prostate specific antigen based screening.

W. Catalona, Misop Han, S. Loeb, 2006, The Journal of urology.

Robustness of free prostate specific antigen measurements to reduce unnecessary biopsies in the 2.6 to 4.0 ng./ml. range.

W. Catalona, K. Roehl, J. Antenor, 2002, The Journal of urology.

Lymphovascular invasion in radical prostatectomy specimens: prediction of adverse pathologic features and biochemical progression.

Ximing J. Yang, W. Catalona, Misop Han, 2006, Urology.

Percent carcinoma in prostatectomy specimen is associated with risk of recurrence after radical prostatectomy in patients with pathologically organ confined prostate cancer.

P. Humphrey, W. Catalona, C. Ramos, 2004, The Journal of urology.

Biopsy of men with PSA level of 2.6 to 4.0 ng/mL associated with favorable pathologic features and PSA progression rate: a preliminary analysis.

W. Catalona, K. Roehl, J. Antenor, 2005, Urology.

Preoperative PSA level significantly associated with interval to biochemical progression after radical retropubic prostatectomy.

W. Catalona, Misop Han, L. W. Blunt, 2004, Urology.

Baseline prostate-specific antigen compared with median prostate-specific antigen for age group as predictor of prostate cancer risk in men younger than 60 years old.

W. Catalona, B. Suarez, R. Nadler, 2006, Urology.

Clinical value of longitudinal free-to-total prostate specific antigen ratio slope to diagnosis of prostate cancer.

W. Catalona, K. Roehl, J. Antenor, 2004, Journal of Urology.

Risk of prostate cancer for young men with a prostate specific antigen less than their age specific median.

W. Catalona, R. Nadler, S. Loeb, 2007, The Journal of urology.

Preoperative PSA and progression-free survival after radical prostatectomy for Stage T1c disease.

W. Catalona, Misop Han, S. Eggener, 2005, Urology.

Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results.

William J Catalona, Misop Han, W. Catalona, 2004, The Journal of urology.

Serial biopsy results in prostate cancer screening study.

William J Catalona, W. Catalona, Kimberly A Roehl, 2002, The Journal of urology.

Association of hemospermia with prostate cancer.

W. Catalona, Misop Han, R. Brannigan, 2004, The Journal of urology.

Potency, continence and complications in 3,477 consecutive radical retropubic prostatectomies.

W. Catalona, Misop Han, S. Eggener, 2004, The Journal of urology.

Pathophysiology of parkinsonism due to hydrocephalus

J. Ojemann, T. Videen, K. Black, 2004, Journal of Neurology, Neurosurgery & Psychiatry.

Screening for prostate cancer in high risk populations.

W. Catalona, J. Moul, K. Roehl, 2002, The Journal of urology.

Accuracy of prostate weight estimation by digital rectal examination versus transrectal ultrasonography.

William J Catalona, Misop Han, W. Catalona, 2005, The Journal of urology.

RE: ASSOCIATION OF HEMOSPERMIA WITH PROSTATE CANCER

W. Catalona, R. Brannigan, K. Roehl, 2005 .

Cortical and subcortical blood flow effects of subthalamic nucleus stimulation in PD

J. Mink, T. Videen, J. Perlmutter, 2003, Neurology.

Relationship between initial prostate specific antigen level and subsequent prostate cancer detection in a longitudinal screening study.

W. Catalona, Misop Han, R. Nadler, 2004, The Journal of urology.

Survival results in patients with screen-detected prostate cancer versus physician-referred patients treated with radical prostatectomy: early results.

W. Catalona, N. Smith, S. Eggener, 2006, Urologic oncology.

Prostate specific antigen density correlates with features of prostate cancer aggressiveness.

W. Catalona, B. Suarez, Xiaoying Yu, 2007, The Journal of urology.

Contemporary survival results and the role of radiation therapy in patients with node negative seminal vesicle invasion following radical prostatectomy.

W. Catalona, Misop Han, N. Smith, 2005, The Journal of urology.

Delays in cancer detection using 2 and 4-year screening intervals for prostate cancer screening with initial prostate specific antigen less than 2 ng/ml.

W. Catalona, Misop Han, R. Grubb, 2005, The Journal of urology.

Overwork weakness in Charcot-Marie-Tooth disease.

Florian P Thomas, C. Esposito, P. Vinci, 2003, Archives of physical medicine and rehabilitation.

Characteristics of patients with familial versus sporadic prostate cancer.

W. Catalona, S. Loeb, K. Roehl, 2006, The Journal of urology.

470: Perineural Invasion: Surrogate Marker for the Extent of Cancer in Radical Prostatectomy Specimens

Joannie T. Yeh, W. Catalona, Misop Han, 2005 .

Results of compliance with prostate cancer screening guidelines.

W. Catalona, R. Grubb, K. Roehl, 2005, The Journal of urology.

Use of 2.6 ng/ml prostate specific antigen prompt for biopsy in men older than 60 years.

W. Catalona, S. Eggener, R. Nadler, 2005, The Journal of urology.

Pathophysiology of parkinsonism due to hydrocephalus

J. Ojemann, T. Videen, K. Black, 2004, Journal of Neurology, Neurosurgery & Psychiatry.